Nachrichten zur NeoGenomics Inc. Aktie

NeoGenomics betreibt eines der führenden Netzwerke für molekulare und oncologische Diagnostik in den USA. Das Unternehmen bietet Onkologen, Krankenhäusern und…

Image source: The Motley Fool.DateTuesday, Feb. 17, 2026 at 8:30 a.m. ETCall participantsChief Executive Officer — Anthony P. ZookChief Financial…

NeoGenomics shares fall over 5% despite earnings beat…

Image source: The Motley Fool.DateFeb. 5, 2026 at 4:30 p.m. ETCall participantsChief Executive Officer — Chad RobinsChief Financial Officer —…

…

Insiders have been trading these 5 stocks: (($GH)), (($JBL)), (($NEO)), (($DRI)) and (($CRMD)). Here is a breakdown of their recent…

…

Neogenomics EVP Olivo sells $250k in NEO stock…

NeoGenomics (NEO) delivered earnings and revenue surprises of +50.00% and +2.27%, respectively, for the quarter ended September 2025. Do the…

Die Aktie des Anbieters von onkologischen Diagnostiktests und Beratungsdienstleistungen befand sich nach einer mehrjährigen Seitwärtsbewegung ab Ende 2024 im steilen…

Detailed price information for Hims & Hers Health Inc (HIMS-N) from The Globe and Mail including charting and trades.…

What Happened? A number of stocks jumped in the afternoon session after news of a new government prescription drug policy…

A number of stocks jumped in the afternoon session after news of a new government prescription drug policy and a…

What Happened? A number of stocks jumped in the afternoon session after news of a new government prescription drug policy…

NeoGenomics (NEO) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong…

What Happened? A number of stocks fell in the afternoon session after the major pulled back (Nasdaq -1.3%, S&P 500 - 1.4%)…

A number of stocks fell in the afternoon session after the major pulled back (Nasdaq -1.3%, S&P 500 - 1.4%)…

NeoGenomics stock tumbles on weak EPS guidance…

NeoGenomics (NEO) delivered earnings and revenue surprises of 100% and 0.92%, respectively, for the quarter ended December 2024. Do the…

NeoGenomics CEO steps down, shares fall 17%…

…

…

…

The Global Bioinformatics Services Market Size was Valued at USD 3.31 Billion in 2023 and the Worldwide Bioinformatics Services Market…

Earnings call: NeoGenomics sees 14% revenue growth in Q1 2024…

…

The consensus price target hints at a 43.3% upside potential for NeoGenomics (NEO). While empirical research shows that this sought-after…